Cold Ethanol Fractionation and Heat Inactivation of Hepatitis A Virus During Manufacture of Albumin from Human Plasma |
Kim, In-Seop
(Department of Biological Sciences, Hannam University)
Park, Yong-Woon (Central Research Center, Green Cross Plasma Derivatives Company) Lee, Sung-Rae (Central Research Center, Green Cross Plasma Derivatives Company) Sung, Hark-Mo (Central Research Center, Green Cross Plasma Derivatives Company) |
1 |
Inactivation of HIV, HBV, HCV related viruses and other viruses in human plasma derivaties by pasteurization
/
|
2 |
Removal and inactivation of human immunodeficiency virus (HIV-1) by cold ethanol fractionation and pasteurization duting the manufacture of albumin and immunoglobulins from hyman plasma
/
과학기술학회마을 DOI ScienceOn |
3 |
Clotting factors and hepatitis A
/
DOI |
4 |
Partitioning and inactivation of viruses by cold ethanol fractionation and pasteurization during manufacture of albumin from human plasma
/
과학기술학회마을 |
5 |
Viral infectivity of albumin and plasma protein fraction
/
|
6 |
pratitioning of hepatitis C virus during Cohn-Oncley fractionation of plasma
/
DOI ScienceOn |
7 |
Clotting factors and hepatitis A
/
DOI |
8 |
Notice on the registration of drugs: Requirements for validation studies to demonstrate the virus safety of drugs derived from human blood of plasma
/
|
9 |
Viral contamination of human plasma and procedures for preventing virus transmission by plasma products
/
|
10 |
Infectious complications of blood transfusion
/
DOI ScienceOn |
11 |
Partitioning and inactivation of viruses during isolation of albumin and immunoglobulins by cold ethanol fractionation
/
|
12 |
Removal and inactivation of hepatitis A virus during manufature of urokinase from human urine
/
과학기술학회마을 DOI ScienceOn |
13 |
/
|
14 |
The epidemiology of virus transmission by plasma dervaives: Clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1
/
DOI ScienceOn |
15 |
Strategies to produce virus-safe blood derivatives
/
|
16 |
Virus safety of plasma products
/
DOI ScienceOn |
17 |
Inactivation and partition of human immunodeficiency virus during Kistler and Nitschmann fractionation of human blood plasma
/
DOI ScienceOn |
18 |
Guidance on viral safety evaluation of biotechnology products derived from cell lines of human of animal origin: Availability
/
|
19 |
Overview of viruses relevant to blood transfusion
/
|
20 |
Inactivation and partition of human T-cell lymphotrophic virus, type Ⅲ, during ethanol fractionation of plasma
/
DOI ScienceOn |
21 |
Preparation and properties of serum and plasma proteins. Ⅳ. A system for the separation into fractions of the proteins and lipoprotein components of biological tissues and fluids
/
DOI |
22 |
An outbreak of hepatitis A among Irish haemophiliacs
/
DOI ScienceOn |